Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Graf

Showing results (161-170 of 318) with videos related to

Pageof 32
Sort By:
Plos One|January 12, 2013
miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastemaJenny A Watson, Kenneth Bryan, Richard Williams, et al.
Complementary Therapies in Medicine|April 13, 2013
Use of complementary and alternative medicine in healthy children and children with chronic medical conditions in GermanySven Gottschling, Benjamin Gronwald, Sarah Schmitt, et al.
IEEE Journal of Biomedical and Health Informatics|May 9, 2014
Web-based workflow planning platform supporting the design and execution of complex multiscale cancer modelsVangelis Sakkalis, Stelios Sfakianakis, Eleftheria Tzamali, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 18, 2007
Wnt signaling pathway analysis in renal cell carcinoma in young patientsElisabeth Bruder, Holger Moch, David Ehrlich, et al.
Cancers|October 13, 2021
Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition SyndromeNils Welter, Angelo Wagner, Rhoikos Furtwängler, et al.
Cancers|November 27, 2021
Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. <i>Cancers</i> 2021, <i>13</i>, 5016Nils Welter, Angelo Wagner, Rhoikos Furtwängler, et al.
Ecancermedicalscience|February 26, 2014
Usability on the p-medicine infrastructure: an extended usability conceptMarie-Luise Christ-Neumann, Ana Escrich, Alberto Anguita, et al.
Pediatric Blood & Cancer|February 15, 2011
Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trialStephan von Hornstein, Rolf-D Kortmann, Torsten Pietsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Advances in Wilms Tumor Treatment and Biology: Progress Through International CollaborationJeffrey S Dome, Norbert Graf, James I Geller, et al.
BMC Genomics|August 9, 2012
Treatment-independent miRNA signature in blood of Wilms tumor patientsJana Schmitt, Christina Backes, Nasenien Nourkami-Tutdibi, et al.
Pageof 32

Showing results (161-170 of 318) with videos related to

Sort By:
Pageof 32
Plos One|January 12, 2013
miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastemaJenny A Watson, Kenneth Bryan, Richard Williams, et al.
Complementary Therapies in Medicine|April 13, 2013
Use of complementary and alternative medicine in healthy children and children with chronic medical conditions in GermanySven Gottschling, Benjamin Gronwald, Sarah Schmitt, et al.
IEEE Journal of Biomedical and Health Informatics|May 9, 2014
Web-based workflow planning platform supporting the design and execution of complex multiscale cancer modelsVangelis Sakkalis, Stelios Sfakianakis, Eleftheria Tzamali, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 18, 2007
Wnt signaling pathway analysis in renal cell carcinoma in young patientsElisabeth Bruder, Holger Moch, David Ehrlich, et al.
Cancers|October 13, 2021
Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition SyndromeNils Welter, Angelo Wagner, Rhoikos Furtwängler, et al.
Cancers|November 27, 2021
Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. <i>Cancers</i> 2021, <i>13</i>, 5016Nils Welter, Angelo Wagner, Rhoikos Furtwängler, et al.
Ecancermedicalscience|February 26, 2014
Usability on the p-medicine infrastructure: an extended usability conceptMarie-Luise Christ-Neumann, Ana Escrich, Alberto Anguita, et al.
Pediatric Blood & Cancer|February 15, 2011
Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trialStephan von Hornstein, Rolf-D Kortmann, Torsten Pietsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Advances in Wilms Tumor Treatment and Biology: Progress Through International CollaborationJeffrey S Dome, Norbert Graf, James I Geller, et al.
BMC Genomics|August 9, 2012
Treatment-independent miRNA signature in blood of Wilms tumor patientsJana Schmitt, Christina Backes, Nasenien Nourkami-Tutdibi, et al.
Pageof 32